autologous tumor cell vaccine
Semantic Scholar uses AI to extract papers important to this topic.
A xenogeneic melanoma-antigen-enhanced allogeneic tumor cell vaccine (ATCV) is an appealing strategy for anti-cancer… Expand For active specific immunotherapy of cancer patients, we designed the autologous virus–modified tumor cell vaccine ATV-NDV. The… Expand AIM
To treat patients with stage I-IV malignant tumors of digestive tract using autologous tumor cell vaccine and NDV (Newcastle… Expand PURPOSE
A reason that the immune system may fail to reject tumors is that T cells encounter tumor antigen derived peptides on the… Expand We performed three multi-institutional, prospectively randomized, controlled clinical trials, assessing the therapeutic effect of… Expand PURPOSE
A randomized phase III clinical trial of adjuvant active specific immunotherapy (ASI) with an autologous tumor cell… Expand An active specific immunization (ASI) procedure with two types of autologous tumor cell vaccines (ATVs) is tested for adjuvant… Expand BACKGROUND
Cancer cells of microscopic metastases can be envisaged as ideal constituents for the development of a genetically… Expand Summary For active specific immunotherapy, autologous tumor cells grown in vitro may be a more appropriate source of tumor… Expand Twenty-four patients with metastatic melanoma were treated with a novel form of active immunotherapy, autologous tumor cell… Expand